TREA

88598278 - CELLREGEN

Follow

Information

  • Trademark
  • 88598278
  • Serial Number
    88598278
  • Filing Date
    August 29, 2019
    4 years ago
  • Transaction Date
    October 25, 2021
    2 years ago
  • Status Date
    October 25, 2021
    2 years ago
  • Published for Opposition Date
    January 26, 2021
    3 years ago
  • Location Date
    March 23, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    NEVILLE, JAMES B
  • Attorney Docket Number
    6300.490
    Attorney Name
    John C. Stringham
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CELLREGEN
Case File Statements
  • GS0011: Biological preparations for others, namely, human cells and tissue for scientific and research use; Cells and biological tissue, namely, human tissue, stem cells, bone marrow, amniotic fluid and blood, for scientific research and use in cellular therapies; biological preparations for others, namely, human cells and tissue, for use in the research of treatment of degenerative diseases, wound healing, and cell therapy
  • GS0051: Biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine
  • GS0351: Business consulting and industry collaboration in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and product development; providing product commercialization assistance in the field of cellular therapy and regenerative medicine; commercialization services in the field of cellular therapy and regenerative medicine
  • GS0401: Contract manufacturing, namely, manufacture of cellular therapies and regenerative medicines; conducting manufacturing support, namely, development of operating procedures and batch records, cell expansion, master and working cell bank production and clinical trials in the field of cellular therapy and regenerative medicine
  • GS0411: Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine
  • GS0421: Conducting clinical trials and research for others in the field of cellular therapy and regenerative medicine; providing medical and scientific research information in the field of clinical trials for cellular therapy and regenerative medicine; Product research and development; Product development consultation; Product research and development services for others in the field of cellular therapy and regenerative medicine; scientific development in the field of stem cells and regenerative medicine; scientific research, discovery, technology transfer, process development and clinical trials in the field of cellular therapy and regenerative medicine
  • GS0441: Medical services in the field of cell-based therapies, including the use of biological cells and tissue in the delivery of cell-based therapies and regenerative medicine; Cell therapy services for the treatment of degenerative diseases, wounds, hematologic diseases, hematologic disorders and immuno-therapy; providing consultancy and information relating to these cell therapies for medical purposes; administration of cell therapies for the treatment of disorders, diseases, and injuries; medical services, namely, isolation of regenerative cells relating to cell therapy services, stem cell collection, processing, phenotypic characterization, infusion and storage for medical and scientific purposes; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; providing educational medical information about cellular therapy and regenerative medicines
Case File Event Statements
  • 10/25/2021 - 2 years ago
    22 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 10/25/2021 - 2 years ago
    21 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 3/23/2021 - 3 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/26/2021 - 3 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/26/2021 - 3 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/6/2021 - 3 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/17/2020 - 3 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/16/2020 - 3 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/15/2020 - 3 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2020 - 3 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/24/2020 - 3 years ago
    12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/24/2020 - 3 years ago
    11 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/24/2020 - 3 years ago
    10 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/4/2020 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/4/2020 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/4/2020 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/4/2019 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/4/2019 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/4/2019 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/2/2019 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/11/2019 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/2/2019 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP